Investor FAQs
Generation Bio is headquartered at 301 Binney Street, Suite 401, Cambridge, MA 02142, US.
Generation Bio was founded and commenced operations in 2016.
Generation Bio’s initial public offering (IPO) occurred on June 11, 2020.
Generation Bio’s fiscal year ends on December 31st.
Generation Bio is traded on the NASDAQ Global Select Market under the ticker symbol GBIO and the CUSIP is 37148K 100.
Computershare Trust Company, N.A.
250 Royall Street
Canton, MA 02021
www.computershare.com
US Phone: +1 800 962 4284
International Phone: +1 781 575 312
Ernst & Young LLP
200 Clarendon St
Boston, MA 02116
(617) 266-2000
Wilmer Cutler Pickering Hale and Dorr LLP
60 State Street
Boston, MA, 02109
(617) 526-6000
Generation Bio’s press release archives can be viewed here.
Generation Bio’s SEC filings can be viewed here.
You can submit queries to Generation Bio’s investor relations department by contacting investors@generationbio.com.